Research ArticleClinical Studies
Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
HIROMICHI KAWAIDA, HIROSHI KONO, HIDETAKE AMEMIYA, RYOU SAITOU, ATSUSHI YAMAMOTO, NAOHIRO HOSOMURA, MITSUAKI WATANABE, AYAKO KIMURA, SHINJI FURUYA, HIROKI SHIMIZU, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, JUN ITAKURA, HIROSHI HAYAKAWA, HIROKO SHINDO, EI TAKAHASHI, SHINICHI TAKANO, MITSUHARU FUKASAWA, SHINTARO ICHIKAWA, HIDEKI FUJII and DAISUKE ICHIKAWA
Anticancer Research November 2018, 38 (11) 6537-6542; DOI: https://doi.org/10.21873/anticanres.13019
HIROMICHI KAWAIDA
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
HIROSHI KONO
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
HIDETAKE AMEMIYA
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
RYOU SAITOU
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
ATSUSHI YAMAMOTO
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
NAOHIRO HOSOMURA
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
MITSUAKI WATANABE
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
AYAKO KIMURA
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
SHINJI FURUYA
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
HIROKI SHIMIZU
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
HIDENORI AKAIKE
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
YOSHIHIKO KAWAGUCHI
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
MAKOTO SUDO
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
JUN ITAKURA
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
HIROSHI HAYAKAWA
2First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
HIROKO SHINDO
2First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
EI TAKAHASHI
2First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
SHINICHI TAKANO
2First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
MITSUHARU FUKASAWA
2First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
SHINTARO ICHIKAWA
3Department of Radiology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
HIDEKI FUJII
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
DAISUKE ICHIKAWA
1First Department of Surgery, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
In this issue
Anticancer Research
Vol. 38, Issue 11
November 2018
Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
HIROMICHI KAWAIDA, HIROSHI KONO, HIDETAKE AMEMIYA, RYOU SAITOU, ATSUSHI YAMAMOTO, NAOHIRO HOSOMURA, MITSUAKI WATANABE, AYAKO KIMURA, SHINJI FURUYA, HIROKI SHIMIZU, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, JUN ITAKURA, HIROSHI HAYAKAWA, HIROKO SHINDO, EI TAKAHASHI, SHINICHI TAKANO, MITSUHARU FUKASAWA, SHINTARO ICHIKAWA, HIDEKI FUJII, DAISUKE ICHIKAWA
Anticancer Research Nov 2018, 38 (11) 6537-6542; DOI: 10.21873/anticanres.13019
Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
HIROMICHI KAWAIDA, HIROSHI KONO, HIDETAKE AMEMIYA, RYOU SAITOU, ATSUSHI YAMAMOTO, NAOHIRO HOSOMURA, MITSUAKI WATANABE, AYAKO KIMURA, SHINJI FURUYA, HIROKI SHIMIZU, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, JUN ITAKURA, HIROSHI HAYAKAWA, HIROKO SHINDO, EI TAKAHASHI, SHINICHI TAKANO, MITSUHARU FUKASAWA, SHINTARO ICHIKAWA, HIDEKI FUJII, DAISUKE ICHIKAWA
Anticancer Research Nov 2018, 38 (11) 6537-6542; DOI: 10.21873/anticanres.13019
Jump to section
Related Articles
- No related articles found.